Aetna Rating Reiterated by Susquehanna (AET)
Aetna (NYSE:AET)‘s stock had its “positive” rating reiterated by investment analysts at Susquehanna in a note issued to investors on Wednesday, Analyst RN reports. They currently have a $76.00 target price on the stock, up from their previous target price of $74.00. Susquehanna’s price objective indicates a potential upside of 18.23% from the stock’s previous close.
The analysts wrote, “We expect the managed care group will post solid third quarter results beginning when UNH kicks of earnings on October 17. The earnings period will matter for the group as Humana will offer specific EPS guidance for 2014 and others, particularly UNH, are likely to offer at least some preliminary expectations for next year.”
Shares of Aetna (NYSE:AET) traded up 0.12% on Wednesday, hitting $64.36. The stock had a trading volume of 194,203 shares. Aetna has a one year low of $40.32 and a one year high of $69.19. The stock’s 50-day moving average is $64.81 and its 200-day moving average is $61.27. The company has a market cap of $23.948 billion and a P/E ratio of 12.81.
Aetna (NYSE:AET) last released its earnings data on Tuesday, July 30th. The company reported $1.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.39 by $0.13. The company had revenue of $11.56 billion for the quarter, compared to the consensus estimate of $12.02 billion. During the same quarter last year, the company posted $1.31 earnings per share. Aetna’s revenue was up 31.0% compared to the same quarter last year. On average, analysts predict that Aetna will post $5.89 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, October 25th. Investors of record on Thursday, October 10th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date of this dividend is Tuesday, October 8th.
Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated an “outperform” rating on shares of Aetna in a research note to investors on Friday, September 27th. They now have a $78.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Aetna from $71.00 to $74.00 in a research note to investors on Tuesday, September 24th. They now have an “overweight” rating on the stock. Finally, analysts at Cantor Fitzgerald reiterated a “hold” rating on shares of Aetna in a research note to investors on Tuesday, September 17th. They now have a $65.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Aetna has an average rating of “Buy” and an average target price of $72.83.
Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.